trending Market Intelligence /marketintelligence/en/news-insights/trending/fqcOC3jUXC9TLmwE1cpKPg2 content esgSubNav
In This List

Astorg backs clinical trial tech platform eResearch

Blog

Balance Sheet Strategy in an Unusual Rate Environment

Blog

Investors' Views of the Industry Today & the Outlook for Tomorrow

Podcast

Street Talk | Episode 98: Regulatory scrutiny having cooling effect on community bank M&A

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion


Astorg backs clinical trial tech platform eResearch

French private equity firm Astorg Partners invested an undisclosed amount in U.S.-based clinical trial technology company, eResearchTechnology Inc., or ERT.

ERT's management team and existing shareholders Nordic Capital and Novo Holdings A/S will reinvest in the company alongside Astorg. Nordic initially invested in the Philadelphia-based data company through its Fund VIII and will reinvest through its Fund IX.

Completion of the transaction is subject to approvals from relevant antitrust authorities.